Total Payments
$3,233
2024 Payments
$831.99
Companies
12
Transactions
110
Medicare Patients
1,438
Medicare Billing
$109,446
Payment Breakdown by Category
Food & Beverage$3,065 (94.8%)
Education$167.98 (5.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,065 | 108 | 94.8% |
| Education | $167.98 | 2 | 5.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | $1,094 | 23 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $920.81 | 31 | $0 (2024) |
| Neurocrine Biosciences, Inc. | $695.37 | 31 | $0 (2024) |
| Sunovion Pharmaceuticals Inc. | $116.84 | 1 | $0 (2019) |
| Vanda Pharmaceuticals Inc. | $109.43 | 6 | $0 (2022) |
| Lundbeck LLC | $107.72 | 6 | $0 (2024) |
| Axsome Therapeutics, Inc. | $44.16 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $37.27 | 2 | $0 (2023) |
| PFIZER INC. | $32.35 | 2 | $0 (2017) |
| Avanir Pharmaceuticals, Inc. | $25.79 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $831.99 | 25 | Teva Pharmaceuticals USA, Inc. ($605.18) |
| 2023 | $933.86 | 25 | Teva Pharmaceuticals USA, Inc. ($421.88) |
| 2022 | $644.54 | 16 | Otsuka America Pharmaceutical, Inc. ($345.95) |
| 2021 | $128.97 | 7 | Neurocrine Biosciences, Inc. ($87.56) |
| 2020 | $221.19 | 13 | Neurocrine Biosciences, Inc. ($115.17) |
| 2019 | $353.80 | 15 | Neurocrine Biosciences, Inc. ($133.51) |
| 2018 | $75.40 | 6 | Neuronetics, Inc. ($23.57) |
| 2017 | $43.03 | 3 | PFIZER INC. ($32.35) |
All Payment Transactions
110 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/02/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: PSYCHIATRY | ||||||
| 11/11/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.85 | General |
| Category: Central Nervous System | ||||||
| 11/04/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Neuropsychiatry | ||||||
| 10/23/2024 | Neurocrine Biosciences, Inc. | — | Food and Beverage | In-kind items and services | $26.09 | General |
| 09/09/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Neuropsychiatry | ||||||
| 08/20/2024 | Teva Pharmaceuticals USA, Inc. | — | Education | In-kind items and services | $71.49 | General |
| 08/20/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $24.56 | General |
| Category: Neurology | ||||||
| 08/06/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $124.74 | General |
| Category: Central Nervous System | ||||||
| 08/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: PSYCHIATRY | ||||||
| 07/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $19.76 | General |
| Category: Central Nervous System | ||||||
| 07/29/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $29.24 | General |
| Category: Neurology | ||||||
| 07/01/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Neuropsychiatry | ||||||
| 06/24/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $20.32 | General |
| Category: Neurology | ||||||
| 05/07/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Central Nervous System | ||||||
| 04/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: Neuropsychiatry | ||||||
| 04/02/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.14 | General |
| Category: PSYCHIATRY | ||||||
| 03/05/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: PSYCHIATRY | ||||||
| 02/26/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: Neuropsychiatry | ||||||
| 02/20/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $107.10 | General |
| Category: Central Nervous System | ||||||
| 02/06/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $119.94 | General |
| Category: Neurology | ||||||
| 02/01/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: NEUROLOGY | ||||||
| 01/29/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $16.03 | General |
| Category: Neuropsychiatry | ||||||
| 01/25/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Central Nervous System | ||||||
| 01/23/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $28.09 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 201 | 420 | $73,653 | $19,554 |
| 2022 | 2 | 274 | 759 | $53,093 | $22,441 |
| 2021 | 2 | 459 | 1,127 | $90,051 | $36,058 |
| 2020 | 3 | 504 | 1,083 | $84,561 | $31,395 |
Total Patients
1,438
Total Services
3,389
Medicare Billing
$109,446
Procedure Codes
10
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2023 | 70 | 70 | $23,520 | $9,036 | 38.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 109 | 328 | $41,984 | $8,134 | 19.4% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 22 | 22 | $8,149 | $2,383 | 29.2% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 199 | 619 | $43,275 | $18,947 | 43.8% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2022 | 75 | 140 | $9,818 | $3,493 | 35.6% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 311 | 813 | $65,312 | $26,283 | 40.2% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 148 | 314 | $24,739 | $9,775 | 39.5% |
| 99212 | Established patient office or other outpatient visit, typically 10 minutes | Office | 2020 | 351 | 848 | $62,950 | $22,938 | 36.4% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 141 | 223 | $19,428 | $7,405 | 38.1% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 12 | 12 | $2,183 | $1,051 | 48.2% |
About Dr. Kyle Smith, D.O
Dr. Kyle Smith, D.O is a Psychiatry healthcare provider based in Troy, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1184663726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kyle Smith, D.O has received a total of $3,233 in payments from pharmaceutical and medical device companies, with $831.99 received in 2024. These payments were reported across 110 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($3,065).
As a Medicare-enrolled provider, Smith has provided services to 1,438 Medicare beneficiaries, totaling 3,389 services with total Medicare billing of $109,446. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Troy, MI
- Active Since 06/06/2006
- Last Updated 06/02/2014
- Taxonomy Code 2084P0800X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1184663726
Products in Payments
- INGREZZA (Drug) $669.28
- REXULTI (Drug) $634.62
- Austedo XR (Drug) $589.18
- NUEDEXTA (Drug) $260.09
- UZEDY (Drug) $227.86
- ABILIFY MAINTENA (Drug) $159.61
- LATUDA (Drug) $116.84
- AUSTEDO (Drug) $108.68
- HETLIOZ (Drug) $59.87
- Fanapt (Drug) $49.56
- Auvelity (Drug) $44.16
- INVEGA SUSTENNA (Drug) $37.27
- QUILLIVANT XR (Drug) $32.35
- NEUROSTAR TMS THERAPY (Device) $23.57
- VYVANSE (Drug) $15.09
- MYDAYIS (Drug) $10.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Troy
Dr. Ariz Anklesaria, D.o, D.O
Psychiatry — Payments: $14,740
Psychiatry $14,740
Dr. Phillip Hash, D.o., Ph.d, D.O., PH.D
Psychiatry — Payments: $12,598
Psychiatry $12,598
Fariha Qadir, M.d, M.D
Psychiatry — Payments: $10,026
Psychiatry $10,026
Naveen Achar, Md, MD
Psychiatry — Payments: $4,753
Psychiatry $4,753
Dr. Cathrine Frank, M.d, M.D
Psychiatry — Payments: $4,479
Psychiatry $4,479
Charles Van Meter, Md, MD
Psychiatry — Payments: $3,574
Psychiatry $3,574